{"id":87488,"date":"2025-10-28T09:42:55","date_gmt":"2025-10-28T08:42:55","guid":{"rendered":"https:\/\/www.cfmot.de\/digitoxin-renaissance-of-a-cardiac-glycoside\/"},"modified":"2025-10-28T09:47:19","modified_gmt":"2025-10-28T08:47:19","slug":"digitoxin-renaissance-of-a-cardiac-glycoside","status":"publish","type":"post","link":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/","title":{"rendered":"Digitoxin: Renaissance of a Cardiac Glycoside"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"87488\" class=\"elementor elementor-87488 elementor-87478\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cc1ff70 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"cc1ff70\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5a0f652\" data-id=\"5a0f652\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c80b4ed elementor-widget elementor-widget-text-editor\" data-id=\"c80b4ed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Digitoxin, a cardiac glycoside derived from the purple foxglove (Digitalis purpurea), is experiencing a remarkable renaissance in modern heart failure therapy thanks to the DIGIT-HF study. The study demonstrates that Digitoxin can significantly reduce the risk of death and hospital admission in patients with systolic heart failure (HFrEF) when added to standard therapy.<\/p><h4>Digitoxin as an Addition to the Four Pillars<\/h4><p>Heart failure treatment is based on four key drug classes:<\/p><p>1. Beta-blockers<\/p><p>2. RAAS inhibitors or ARNI (Angiotensin Receptor-Neprilysin Inhibitors)<\/p><p>3. Mineralocorticoid Receptor Antagonists (MRA)<\/p><p>4. SGLT2 inhibitors<\/p><p>These medications improve prognosis and quality of life for patients with HFrEF. Yet despite these advances, mortality remains high. This is where Digitoxin comes in\u2014as a fifth pillar that meaningfully complements the existing treatment concept.<\/p><h4>Compound Profile: Digitoxin in Detail<\/h4><p>Digitoxin is a natural steroid glycoside extracted from the leaves of Digitalis purpurea. It consists of the aglycone digitoxigenin and three sugar residues (digitoxose). The substance acts as a positive inotrope by inhibiting the sodium-potassium ATPase, leading to increased intracellular calcium and stronger heart muscle contractions.<\/p><p>Additionally, Digitoxin has:<\/p><p>\u2022 Negative chronotropic effects (slows heart rate)<\/p><p>\u2022 Negative dromotropic effects (slows conduction)<\/p><p>\u2022 Positive bathmotropic effects (increases excitability of the heart muscle)<\/p><p>A key advantage: Digitoxin is metabolized by the liver, not the kidneys, making it suitable for patients with impaired renal function. Its long half-life (6\u20138 days) and high bioavailability also make it highly controllable.<\/p><h4>Clinical Relevance of the DIGIT-HF Study<\/h4><p>The DIGIT-HF study observed over 1,200 patients with advanced heart failure (NYHA III\u2013IV) over three years. The Digitoxin group showed a significant relative risk reduction of 18% in the primary endpoint: death or hospital admission due to worsening heart failure. Patients with low blood pressure and elevated heart rate benefited particularly.<\/p><h4>A Compound with History and Future<\/h4><p>Digitoxin is more than a traditional compound. It\u2019s a prime example of how plant-based natural substances can regain clinical relevance through modern research.<\/p><p><strong>We supply both the plant-based raw material and the pure compound Digitoxin. Feel free to contact us with any questions.<\/strong><\/p><p>Sources:<\/p><p>\u2022 <a href=\"https:\/\/www.aerztezeitung.de\/Medizin\/DIGIT-HF-Studie-Digitoxin-von-klinischem-Nutzen-bei-Herzinsuffizienz-459990.html\">\u00c4rztezeitung: DIGIT-HF-Studie \u2013 Digitoxin von klinischem Nutzen [aerztezeitung.de]<\/a><\/p><p>\u2022 <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2415471\">New England Journal of Medicine: Originalpublikation zur DIGIT-HF-Studie [mhh.de]<\/a><\/p><p>\u2022 <a href=\"https:\/\/www.pharmazeutische-zeitung.de\/digitoxin-besser-als-sein-ruf-158567\/\">Pharmazeutische Zeitung: Digitoxin besser als sein Ruf [pharmazeut&#8230;zeitung.de]<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Digitoxin, a cardiac glycoside derived from the purple foxglove (Digitalis purpurea), is experiencing a remarkable renaissance in modern heart failure therapy thanks to the DIGIT-HF study. The study demonstrates that Digitoxin can significantly reduce the risk of death and hospital admission in patients with systolic heart failure (HFrEF) when added to standard therapy. Digitoxin as [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":87487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[48,137,139,138],"tags":[],"class_list":["post-87488","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en-2","category-medicinal-plants","category-pharmaceutical-products","category-phytochemicals"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH\" \/>\n<meta property=\"og:description\" content=\"Digitoxin, a cardiac glycoside derived from the purple foxglove (Digitalis purpurea), is experiencing a remarkable renaissance in modern heart failure therapy thanks to the DIGIT-HF study. The study demonstrates that Digitoxin can significantly reduce the risk of death and hospital admission in patients with systolic heart failure (HFrEF) when added to standard therapy. Digitoxin as [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/\" \/>\n<meta property=\"og:site_name\" content=\"Cfm Oskar Tropitzsch GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T08:42:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T08:47:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karin Bayer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karin Bayer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/\"},\"author\":{\"name\":\"Karin Bayer\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/0192b39a358835d45c94562d47c033c7\"},\"headline\":\"Digitoxin: Renaissance of a Cardiac Glycoside\",\"datePublished\":\"2025-10-28T08:42:55+00:00\",\"dateModified\":\"2025-10-28T08:47:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/\"},\"wordCount\":369,\"image\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/roter-Fingerhut-1600.jpg\",\"articleSection\":[\"Blog\",\"Medicinal Plants\",\"Pharmaceutical Products\",\"Phytochemicals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/\",\"name\":\"Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/roter-Fingerhut-1600.jpg\",\"datePublished\":\"2025-10-28T08:42:55+00:00\",\"dateModified\":\"2025-10-28T08:47:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/0192b39a358835d45c94562d47c033c7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/roter-Fingerhut-1600.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cfmot.de\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/roter-Fingerhut-1600.jpg\",\"width\":1600,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/digitoxin-renaissance-of-a-cardiac-glycoside\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Digitoxin: Renaissance of a Cardiac Glycoside\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/\",\"name\":\"Cfm Oskar Tropitzsch GmbH\",\"description\":\"Chemikalien, Feinchemikalien, Metallverbindungen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/#\\\/schema\\\/person\\\/0192b39a358835d45c94562d47c033c7\",\"name\":\"Karin Bayer\",\"url\":\"https:\\\/\\\/www.cfmot.de\\\/en\\\/author\\\/karin-bayer\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/","og_locale":"en_US","og_type":"article","og_title":"Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH","og_description":"Digitoxin, a cardiac glycoside derived from the purple foxglove (Digitalis purpurea), is experiencing a remarkable renaissance in modern heart failure therapy thanks to the DIGIT-HF study. The study demonstrates that Digitoxin can significantly reduce the risk of death and hospital admission in patients with systolic heart failure (HFrEF) when added to standard therapy. Digitoxin as [&hellip;]","og_url":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/","og_site_name":"Cfm Oskar Tropitzsch GmbH","article_published_time":"2025-10-28T08:42:55+00:00","article_modified_time":"2025-10-28T08:47:19+00:00","og_image":[{"width":1600,"height":1000,"url":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg","type":"image\/jpeg"}],"author":"Karin Bayer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karin Bayer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#article","isPartOf":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/"},"author":{"name":"Karin Bayer","@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/0192b39a358835d45c94562d47c033c7"},"headline":"Digitoxin: Renaissance of a Cardiac Glycoside","datePublished":"2025-10-28T08:42:55+00:00","dateModified":"2025-10-28T08:47:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/"},"wordCount":369,"image":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg","articleSection":["Blog","Medicinal Plants","Pharmaceutical Products","Phytochemicals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/","url":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/","name":"Digitoxin: Renaissance of a Cardiac Glycoside - Cfm Oskar Tropitzsch GmbH","isPartOf":{"@id":"https:\/\/www.cfmot.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#primaryimage"},"image":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg","datePublished":"2025-10-28T08:42:55+00:00","dateModified":"2025-10-28T08:47:19+00:00","author":{"@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/0192b39a358835d45c94562d47c033c7"},"breadcrumb":{"@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#primaryimage","url":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg","contentUrl":"https:\/\/www.cfmot.de\/wp-content\/uploads\/2025\/10\/roter-Fingerhut-1600.jpg","width":1600,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/www.cfmot.de\/en\/digitoxin-renaissance-of-a-cardiac-glycoside\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cfmot.de\/en\/"},{"@type":"ListItem","position":2,"name":"Digitoxin: Renaissance of a Cardiac Glycoside"}]},{"@type":"WebSite","@id":"https:\/\/www.cfmot.de\/en\/#website","url":"https:\/\/www.cfmot.de\/en\/","name":"Cfm Oskar Tropitzsch GmbH","description":"Chemikalien, Feinchemikalien, Metallverbindungen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cfmot.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.cfmot.de\/en\/#\/schema\/person\/0192b39a358835d45c94562d47c033c7","name":"Karin Bayer","url":"https:\/\/www.cfmot.de\/en\/author\/karin-bayer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/87488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/comments?post=87488"}],"version-history":[{"count":4,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/87488\/revisions"}],"predecessor-version":[{"id":87492,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/posts\/87488\/revisions\/87492"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/media\/87487"}],"wp:attachment":[{"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/media?parent=87488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/categories?post=87488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cfmot.de\/en\/wp-json\/wp\/v2\/tags?post=87488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}